Xponance Inc. Decreases Stake in Humana Inc. (NYSE:HUM)

Xponance Inc. cut its holdings in shares of Humana Inc. (NYSE:HUM) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,415 shares of the insurance provider’s stock after selling 1,676 shares during the period. Xponance Inc.’s holdings in Humana were worth $9,804,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. State Street Corp boosted its position in shares of Humana by 0.5% during the first quarter. State Street Corp now owns 5,708,167 shares of the insurance provider’s stock valued at $2,776,072,000 after purchasing an additional 25,832 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Humana by 0.8% in the first quarter. Geode Capital Management LLC now owns 2,234,477 shares of the insurance provider’s stock worth $1,082,060,000 after acquiring an additional 16,692 shares in the last quarter. Morgan Stanley boosted its holdings in Humana by 6.2% in the third quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider’s stock worth $992,938,000 after acquiring an additional 119,760 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in Humana by 35.9% in the third quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after acquiring an additional 402,559 shares in the last quarter. Finally, Norges Bank bought a new stake in Humana in the fourth quarter worth $690,516,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. TD Cowen dropped their target price on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a report on Tuesday, April 2nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $391.00 price target on shares of Humana in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating and lowered their price target for the company from $595.00 to $360.00 in a report on Thursday, January 25th. TheStreet downgraded Humana from a “b” rating to a “c+” rating in a report on Monday, January 8th. Finally, Argus downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus price target of $465.42.

Humana Stock Performance

HUM traded up $2.79 during midday trading on Friday, reaching $327.62. The company had a trading volume of 85,075 shares, compared to its average volume of 1,983,403. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The business has a 50-day moving average of $343.55 and a two-hundred day moving average of $425.01. The company has a market cap of $39.53 billion, a P/E ratio of 16.39, a P/E/G ratio of 1.90 and a beta of 0.45. Humana Inc. has a 1 year low of $299.23 and a 1 year high of $541.21.

Humana (NYSE:HUM) last issued its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The company had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The business’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.62 EPS. As a group, equities research analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.08%. Humana’s payout ratio is 17.86%.

Insiders Place Their Bets

In related news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.